Delivery Order SPE2DB24D3013-SPE2DB25FFMXW

Award Date 6/27/25
Potential Completion Date 7/21/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm-fixed-price delivery order is for TABRECTA 200 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $13,094.84 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $13,094.84, is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, under a firm fixed price delivery order. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $6,547.42 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of September 27, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,094.84, is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 7, 2024. This delivery order does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of the pharmaceutical product TABRECTA 200 MG TABLET UU 56S, with a ceiling value of $13,094.84 and a period of performance through April 10, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
This federal contract award is for the delivery of TABRECTA 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $13,094.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as the...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $13,094.84. The order is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of March 21, 2024. This Delivery Order does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFD89, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, with an ultimate completion date of February 10, 2025 and a ceiling value of $28,856.12. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award....
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFMXW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $14,428.06 and a performance period through July 21, 2025. This contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/26/25, 9:54 AM